Heart failure with preserved ejection fraction is a heterogeneous syndrome ... and objective evidence of left ventricular diastolic dysfunction or raised left ventricular filling pressures.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

Patients with ejection fraction <40% were excluded ... placebo on the functional status of elderly patients with diastolic heart failure. [21] This was a smaller study that enrolled 74 patients ...

Diastolic heart failure is defined clinically when signs and symptoms of heart failure are present in the presence of preserved left ventricular systolic function (ejection fraction >45%).

AI model transforms heart failure care by precisely identifying cases and enhancing quality evaluations in clinical practice.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Many studies have reported that obesity causes heart failure (HF) pathogenesis.

The following is a summary of “Unmasking High-Output Heart Failure: Beyond Conventional Paradigms,” published in the January ...

Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...